Tag Archives: GHDX

Hot Value Stocks To Invest In Right Now

SG Americas Securities LLC raised its stake in shares of Milacron Holdings Corp (NYSE:MCRN) by 34.7% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 12,820 shares of the industrial products company’s stock after buying an additional 3,304 shares during the period. SG Americas Securities LLC’s holdings in Milacron were worth $258,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Xact Kapitalforvaltning AB purchased a new position in shares of Milacron during the 4th quarter valued at about $193,000. OppenheimerFunds Inc. purchased a new position in shares of Milacron during the 4th quarter valued at about $201,000. US Bancorp DE raised its stake in shares of Milacron by 95.8% during the 4th quarter. US Bancorp DE now owns 12,948 shares of the industrial products company’s stock valued at $248,000 after buying an additional 6,335 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of Milacron during the 4th quarter valued at about $284,000. Finally, Teacher Retirement System of Texas purchased a new position in shares of Milacron during the 4th quarter valued at about $454,000. Institutional investors and hedge funds own 99.38% of the company’s stock.

Hot Value Stocks To Invest In Right Now: Plains Group Holdings, L.P.(PAGP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TheStreet upgraded shares of Plains GP (NYSE:PAGP) from a d+ rating to a c- rating in a research report released on Monday morning.

    Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut Plains GP from a buy rating to a hold rating and set a $24.00 price objective on the stock. in a report on Wednesday. Jefferies Group cut Plains GP from a buy rating to a hold rating in a report on Wednesday, April 25th. Wolfe Research cut Plains GP from a market perform rating to an underperform rating in a report on Tuesday, April 24th. Deutsche Bank began coverage on Plains GP in a report on Thursday, April 19th. They set a buy rating and a $29.00 price objective on the stock. Finally, SunTrust Banks raised Plains GP from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Monday, April 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $25.65.

  • [By Shane Hupp]

    News coverage about Plains GP (NYSE:PAGP) has been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Plains GP earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the pipeline company an impact score of 46.0549967457103 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Plains GP alerts:

    Plains GP (PAGP) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS (americanbankingnews.com) Plains GP (PAGP) Upgraded by TheStreet to C- (americanbankingnews.com) Plains GP (PAGP) Downgraded by Stifel Nicolaus (americanbankingnews.com) Plains GP Holdings (PAGP) Tops Q1 EPS by 5c, Beats on Revenues (streetinsider.com) Plains All American Pipeline, L.P. and Plains GP Holdings Report First-Quarter 2018 Results (finance.yahoo.com)

    Several research firms have commented on PAGP. TheStreet upgraded shares of Plains GP from a “d+” rating to a “c-” rating in a research report on Monday. Stifel Nicolaus cut shares of Plains GP from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Wednesday. Jefferies Group cut shares of Plains GP from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. Wolfe Research cut shares of Plains GP from a “market perform” rating to an “underperform” rating in a research report on Tuesday, April 24th. Finally, Deutsche Bank began coverage on shares of Plains GP in a research report on Thursday, April 19th. They issued a “buy” rating and a $29.00 target price for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $25.65.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Plains GP (PAGP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Two years ago, Plains All American Pipeline (NYSE:PAA) and Plains GP Holdings (NYSE:PAGP) took a step to simplify their corporate structure by eliminating the costly incentive distribution rights (IDRs) that Plains All American paid to Plains GP. In exchange, Plains GP acquired a 34.8% stake in the MLP. While that deal was certainly a step in the right direction, the companies could eventually take the next logical progression by combining into one entity.

  • [By Joseph Griffin]

    Plains GP (NYSE:PAGP) was downgraded by equities researchers at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a note issued to investors on Monday, The Fly reports.

Hot Value Stocks To Invest In Right Now: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Rich Duprey]

    Starbucks (NASDAQ:SBUX) may consider itself a “third place” (after the home and the workplace) for people, but it should place first in the minds of those looking for a quality investment.

  • [By Chris Lange]

    Starbucks Corp. (NASDAQ: SBUX) saw its shares dip on Wednesday after the company announced that it would be undertaking new initiatives to help grow the company in the United States and China. Part of these initiatives would be accelerating its store closures as a result of sluggish sales.

  • [By ] When it comes to mobile payments, most people likely think ofApple(NASDAQ: AAPL) Pay or Alphabet’s (NASDAQ: GOOG)(NASDAQ: GOOGL) Google Pay. However, a recent eMarketer studyfound that Starbucks(NASDAQ: SBUX) actually has the top proximity mobile payment app in the United States.

  • [By Logan Wallace]

    Starbucks (NASDAQ: SBUX) and GREENE KING PLC/S (OTCMKTS:GKNGY) are both retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Hot Value Stocks To Invest In Right Now: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Max Byerly]

    Genomic Health (NASDAQ:GHDX) – Stock analysts at William Blair issued their Q1 2019 earnings estimates for Genomic Health in a research note issued to investors on Monday, June 4th. William Blair analyst A. Murphy forecasts that the medical research company will post earnings of $0.12 per share for the quarter. William Blair also issued estimates for Genomic Health’s Q2 2019 earnings at $0.16 EPS, Q3 2019 earnings at $0.20 EPS and Q4 2019 earnings at $0.21 EPS.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s scoring:

    Get Genomic Health alerts:

    Zacks: Brokerages Expect Genomic Health, Inc. (GHDX) to Post $0.07 EPS (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 8.5% (finance.yahoo.com) Genomic Health (GHDX) vs. Veracyte (VCYT) Head-To-Head Contrast (americanbankingnews.com) PetMed (PETS) Optimistic About New Orders Amid Cost Woes (finance.yahoo.com) Genomic Health Inc. (GHDX) PT Raised to $56 at Canaccord Genuity (streetinsider.com)

    Genomic Health stock traded up $0.57 during mid-day trading on Wednesday, hitting $50.58. 868 shares of the company’s stock were exchanged, compared to its average volume of 337,252. The company has a market capitalization of $1.76 billion, a price-to-earnings ratio of 5,058.00 and a beta of 0.64. Genomic Health has a 1-year low of $26.54 and a 1-year high of $53.65.

  • [By Stephan Byrd]

    Genomic Health, Inc. (NASDAQ:GHDX) insider Kimberly J. Popovits sold 10,000 shares of Genomic Health stock in a transaction on Thursday, June 14th. The shares were sold at an average price of $48.89, for a total value of $488,900.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

Hot Value Stocks For 2018

Hit games are a weird thing. They can sometimes come out of nowhere, and sometimes can be considered an inevitability. Many thought games such as Grand Theft Auto V by Take-Two Interactive (NASDAQ:TTWO) or any version of Call of Duty by Activision (NASDAQ:ATVI) would undoubtedly do very well and would likely be hits. Others took the market by surprise, Pok茅mon Go by Niantic/Nintendo (OTCPK:NTDOY) and Kim Kardashian Hollywood by Glu Mobile (NASDAQ:GLUU) come to mind. In general, it seems, mobile games have a greater propensity to come from the flank, becoming hit games to the surprise of even the most learned gaming experts. Maybe it has something to do with the mobile form factor, or maybe it’s the sheer amount of capital thrown at hit console games nearly guaranteeing they will be successful.

The mobile battlefield is full of games that came out of nowhere, Candy Crush, Clash of Clans, Summoners War, Episode – Choose Your Story and more recently, Archery King. The hits of tomorrow on this field are potentially not even out yet, at the very least, not a “hit” game yet. Mobile gaming executives have tried their hardest; they don’t want their industry to be viewed as hit-driven. No, they try to sell the portfolio of games narrative as much as investors have the patience to hear about it. Investors don’t seem to care. A nice solid portfolio is great but when the portfolio often produces ever-diminishing revenue quarter after quarter investors become tired of hearing how great a company’s “portfolio” might be. What we have seen in the industry are names that investors have become tired with, picked off by larger, more established gaming companies that see the value.

Hot Value Stocks For 2018: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

Hot Value Stocks For 2018: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

Hot Value Stocks For 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

Top Stocks To Buy For 2018

Peter Krauth

The price of gold today (Friday, April 7) is at its highest level in nearly five months as investors buy safe havens in the wake of the Syrian air strike. As of 8:30 a.m., the metal is up 1.5% and trading at $1,272. That’s the highest since prices closed at $1,273 on Nov. 9, 2016.

It’s clear that gold’s been acting well of late, despite some renewed strength in the dollar.

Meanwhile, stocks appear to be stalling, while oil prices have bounced back and 10-year Treasuries have gained as well.

If we look at the gold price performance over the first quarter, there’s nothing to complain about. The precious metal gained 8.6% from Jan. 1 to March 31 and is currently up 10.4% on the year.

Compare that to just a 5.3% gain for the S&P 500 and you can see why gold is a great way to beat the broader market.

Top Stocks To Buy For 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

Top Stocks To Buy For 2018: region(XIV)

Advisors’ Opinion:

  • [By Money Morning News Team]

    This led some traders to purchase leveraged ETFs that move inverse to the VIX, like theVelocityShares Daily Inv VIX Short Term(Nasdaq: XIV).

    The VIX is a derivative of the broad S&P 500, and the XIV is a derivative of that derivative.

Top Stocks To Buy For 2018: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Jayson Derrick]

    Other stocks that were net sold include ConocoPhillips (NYSE: COP) and Kinder Morgan Inc (NYSE: KMI). Tesla Inc (NASDAQ: TSLA) was also sold by clients after the electric vehicle maker saw its stock hit a new all-time high in the middle of the month.

  • [By Shanthi Rexaline]

    Phillips 66 is a multi-national company headquartered in Westchase, Houston. It was spun off from ConocoPhillips (NYSE: COP) in 1917.

    Stock Return (Since 2012): 144.1 percent.

  • [By Max Byerly]

    ConocoPhillips (NYSE:COP) SVP Janet Langford Kelly sold 59,389 shares of the firm’s stock in a transaction dated Thursday, May 3rd. The shares were sold at an average price of $65.95, for a total value of $3,916,704.55. Following the completion of the transaction, the senior vice president now directly owns 100,600 shares in the company, valued at $6,634,570. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Matthew DiLallo]

    Meanwhile, ConocoPhillips (NYSE:COP) also abandoned its leases in the Chukchi Sea earlier this year. It paid $506 million for the 98 leases off Alaska’s northern coast in 2008 and had plans to drill its first exploratory well in 2014 but dropped those ambitions due to regulatory uncertainty. It has also since decided to exit deepwater exploration altogether after drilling a string of dry holes in the Gulf of Mexico, offshore Angola, and the Canadian Atlantic, Instead, ConocoPhillips plans to focus its future development efforts on lower-risk onshore shale development.

  • [By Chris Dier-Scalise]

    Among the brands being sold were Alcoa Corporation (NYSE: AA) and Ford Motor Company(NYSE: F), which both paid out dividends in December. The financial and oil sectors also experienced a sell-off to finish 2016. Wells Fargo & Co (NYSE: WFC) and Citigroup Inc (NYSE: C) were net sold as each reached new year-to-date highs and investors unloaded ConocoPhillips (NYSE: COP) and Chevron Corporation (NYSE: CVX) as their prices normalized with the rise in the price of oil.

  • [By WWW.KIPLINGER.COM]

    Spun off from energy producer ConocoPhillips (COP) a few years back, PSX has quickly become one of the downstream industrys biggest players. Refiners earn profits based on the difference between feed stock costs (Think oil and natural gas prices) and the price for refined products such as gasoline, jet fuel and heating oil. Those inputs remain low, and Phillips 66 is minting cash as a result.

Top Stocks To Buy For 2018: CareTrust REIT, Inc.(CTRE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CareTrust REIT (NASDAQ:CTRE) issued its earnings results on Tuesday. The real estate investment trust reported $0.32 EPS for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.01, Briefing.com reports. The business had revenue of $38.10 million during the quarter, compared to analysts’ expectations of $36.99 million. CareTrust REIT had a net margin of 19.46% and a return on equity of 4.37%. The company’s quarterly revenue was up 24.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.30 earnings per share. CareTrust REIT updated its FY18 guidance to $1.26-$1.28 EPS.

  • [By Jason Hall, Chuck Saletta, and Reuben Gregg Brewer]

    But that doesn’t mean you need to make risky bets to capture solid returns, either, and buying solid companies at reasonable prices can help create a margin of safety and improve your returns, while also decreasing your risk of permanent losses. Three stocks that meet these criteria are small healthcare real-estate specialistCaretrust REIT Inc(NASDAQ:CTRE), financial services giantPrudential Financial Inc(NYSE:PRU), and energy behemothExxonMobil Corporation(NYSE:XOM).

  • [By Max Byerly]

    BidaskClub upgraded shares of CareTrust REIT (NASDAQ:CTRE) from a strong sell rating to a sell rating in a report issued on Wednesday.

    Several other equities analysts have also recently weighed in on the company. Royal Bank of Canada reiterated a hold rating and set a $15.00 price objective on shares of CareTrust REIT in a report on Tuesday, March 6th. Zacks Investment Research cut CareTrust REIT from a hold rating to a sell rating in a research note on Monday, January 15th. Stephens set a $19.00 target price on CareTrust REIT and gave the company a buy rating in a research note on Friday, January 12th. Cantor Fitzgerald initiated coverage on CareTrust REIT in a research note on Monday, March 5th. They issued an overweight rating and a $16.00 target price on the stock. Finally, BMO Capital Markets restated a hold rating and issued a $15.00 target price on shares of CareTrust REIT in a research note on Tuesday, March 27th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company. CareTrust REIT currently has a consensus rating of Hold and an average price target of $17.90.

  • [By Monica Gerson]

    Caretrust REIT Inc (NASDAQ: CTRE) is estimated to post its quarterly earnings at $0.26 per share on revenue of $22.21 million.

    China Lodging Group, Ltd (ADR) (NASDAQ: HTHT) is projected to post its quarterly earnings at $0.41 per share on revenue of $1.39 billion.

Top Stocks To Buy For 2018: Fox Factory Holding Corp.(FOXF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Fox Factory Holding Corp (NASDAQ: FOXF) was down 1.8 percent after posting a 2.16 percent rise over the day.

    Finally, Groupon Inc (NASDAQ: GRPN) gained 1.3 percent, continuing with the 3.85 percent spike it experienced on Friday trading.

Best Casino Stocks To Invest In 2018

Elliott R. Morss Ph.D. 漏All Rights Reserved

Introduction

Politicians in Massachusetts, New York and Rhode Island have put aside moral and/or addiction concerns over gambling. Instead, they recently asked why all the gambling dollars from their citizens go to the casinos (and governments) in Connecticut and New Jersey. They responded by approving for new gaming facilities in all three states. Below, data on these actions is presented with commentary.

The Current Situation

Table 1 provides gambling revenues and how they have changed since 2007 for northeast US states, with California, Nevada and Macau included as points of reference. The growth in Macau has been truly amazing. And additional facilities continue to be built there. However, as noted in an earlier piece, Japan has just approved a number of new integrated resort casinos. And these can be expected to siphon off some of the gambling from Macau, Singapore, Malaysia and Australia.

Gambling revenues in Nevada, New Jersey, and Connecticut have not recovered from the 2008 global recession caused by the US banking collapse.

Best Casino Stocks To Invest In 2018: News Corporation(NWS)

Advisors’ Opinion:

  • [By Monica Gerson]

    News Corp (NASDAQ: NWS) reported a profit of $506 million, or $0.87 per share for the year ended June 30, versus a year-ago loss of $2.08 billion, or $3.58 per share. Its revenue rose 2.7% to $8.89 billion. However, analysts were expecting earnings of $0.57 per share on revenue of $8.96 billion. News Corp shares fell 1.28% to close at $16.91 on Friday.

Best Casino Stocks To Invest In 2018: Berkshire Hathaway Inc. (BRK-B)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Billionaire investor Warren Buffett, for his part, has added fuel to Apple's recent rally by increasing his stake in the company in a big way. The 13D filing done by Buffett's Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) following the end of the fourth quarter of 2016 showed that it had nearly quadrupled its position in Apple.

  • [By John Maxfield]

    Since the beginning of 2016, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has seen the value of the seven bank stocks in its investment portfolio increase by $5.6 billion, or 10.8%.

  • [By Matthew Frankel]

    While it’s technically not a pure insurance stock, that’s exactly why I suggest Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) for investors who want a piece of the insurance business.

Best Casino Stocks To Invest In 2018: US Ecology, Inc.(ECOL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    US Ecology (NASDAQ: ECOL) and Republic Services (NYSE:RSG) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Best Casino Stocks To Invest In 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.

Best Casino Stocks To Invest In 2018: NextEra Energy, Inc.(NEE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
    Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
    Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
    General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
    Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
    Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
    Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
    SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
    ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
    Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
    Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
    WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
  • [By Elizabeth Loring]

    Yesterday, Northern Vertex Mining Corp. (TSX.V: NEE) announced the closing of a tranche of its non-brokered private placement as previously announced on May 26, 2017, raising gross proceeds to the Company of $2,783,300. Additionally, Northern Vertex announced that it received $1,134,000 from the exercise of certain warrants, which were due to expire between July 3 and 11, 2017. The company intends to use the net proceeds of the Private Placement for the continued development and construction of its Moss Mine Gold/Silver Project located in Mohave County, Arizona.